654 (Glyburide and Metformin Hydrochloride 2.5 mg / 500 mg)
Pill with imprint 654 is Yellow, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 2.5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 654
Glyburide and Metformin Hydrochloride
- Imprint:
- 654
- Strength:
- 2.5 mg / 500 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cadila Healthcare Limited
- National Drug Code (NDC):
- 65841-0825
More about glyburide/metformin
- Glyburide/metformin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (1)
Consumer resources
Other brands: Glucovance
Professional resources
- Glyburide and Metformin (FDA)
- Glyburide and Metformin Tablets (FDA)
- Glyburide and Metformin (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
